MedTrace Logo

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

NCT01624116 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2012-06-20

No results posted yet for this study

Summary

Type 2 diabetic patients who fast during Ramadan experience swings in glycaemic control between hypoglycaemic troughs and hyperglycaemic spikes. Hence, the dual challenge in fasting diabetics is to identify which treatment modality leads to the most stable blood glucose levels during a fast and how to smooth out these excursions and reduce risks of fast to a minimum.

Conditions

  • Diabetes, Type 2

Interventions

DRUG

Acarbose

Tab.Acarbose 50mg BD for one day in addition to existing medication to 10% of patients in each treatment arm.

OTHER

Diet and lifestyle

Patients would follow a 1200 KCal Ramadan diet plan, and exercise for 30 minutes per day

DRUG

Metformin

Patients on metformin monotherapy prior to Ramadan will continue on it, in the same dose

DRUG

Metformin/ Glimepride

Metformin 500mg and Glimepride 1mg in a combination tablet. Dosage frequency BD

DRUG

Metformin/Sitagliptin

Metformin 500 and sitagliptin 50mg in a combination tablet,dosage frequency BD.

Sponsors & Collaborators

  • Services Hospital, Lahore

    lead OTHER_GOV

Principal Investigators

  • Dr Khadija Irfan, MBBS,FCPS · Services Hospital.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01624116 on ClinicalTrials.gov